Polygonatum polysaccharide microspheres encapsulated living Clostridium butyricum for mucosal barrier repair and immune regulation Authors: Qinglian Hu, Xiangchi Xu, Jing Feng, Jiyue Hu, Chaozhi Wei, Jintao Cheng, Yue Chen, Yuanxiang Jin Published: 2026 ABSTRACT AbstractA collaborative intervention strategy based on probiotics represents a promising therapeutic approach against inflammatory bowel disease (IBD). However, enhancing probiotic efficacy within the IBD microenvironment while minimizing side effects remains a critical challenge. Polygonatum polysaccharide (PP), a natural plant-derived bioactive polymer, has attracted significant attention due to its ability to regulate oxidative and inflammatory stress with a favorable safety profile. Herein, PP was incorporated into calcium-alginate microgels (Mgel), resulting in enhanced mechanical strength and thermal stability. Compared to conventional calcium-alginate microgels, the PP-loaded microgels exhibited improved performance in oral delivery. In addition, PP functions as a promising microenvironmental modulator, exhibiting broad-spectrum antioxidant, anti-inflammatory, and prebiotic properties. The microgel system provides a versatile platform for probiotic oral delivery, contributing to the reshaping of the IBD microenvironment by enhancing the efficacy of Clostridium butyricum JHP6 and increasing beneficial metabolite levels in colitis. Collectively, naturally derived polysaccharide-based microspheres encapsulating probiotics offer an effective strategy to modulate the IBD microenvironment and enhance probiotic efficacy, thereby representing a collaborative intervention approach for IBD.Graphical Abstract Supplementary InformationThe online version contains supplementary material available at 10.1186/s12951-026-04613-w.Keywords: Clostridium butyricum, Polygonatum polysaccharide, Microspheres, Inflammatory bowel disease, Mitochondrial dysfunction Introduction Inflammatory bowel disease (IBD) is a progressive, chronic disorder characterized by persistent inflammation and epithelial damage within the gastrointestinal tract (GIT) [1]. Current anti-inflammatory treatments primarily aim to suppress aberrant intestinal inflammatory responses. However, they do not directly promote mucosal healing, exhibit limited clinical efficacy, and are often accompanied by severe side effects [2]. Although newly developed biologic agents and small-molecule drugs show promising therapeutic effects [3, 4], a compromised intestinal barrier may still permit exogenous substances to trigger recurrent inflammation [5]. Therefore, targeted therapies aimed at preserving mucosal integrity and mitigating gut inflammation may offer promising and practical treatment strategies [6, 7]. Butyrate, a short-chain fatty acid (SCFA) produced by colonic microbial fermentation, is well known for its anti-inflammatory effects in the colon [8]. Over the past two decades, studies have demonstrated the beneficial effects of butyrogenic diets, oral butyrate supplementation, and butyrate enemas in reducing inflammation in both colitis animal models and IBD patients [9]. Emerging evidence indicates that butyrate, functioning as both a key energy source and a signaling molecule, plays a vital role in regulating epithelial barrier integrity and modulating both mucosal and systemic immune responses [10]. A reduced abundance of butyrate-producing commensal bacteria has been implicated in the pathogenesis of IBD [11]. Oral administration of butyrate-producing bacteria has shown promising proof-of-concept efficacy in preclinical models of colitis [12, 13]. However, the complex GIT often results in substantial probiotic loss and poor colonization or proliferation, underscoring a major bottleneck in probiotic-based therapies [14]. Thus, there is an urgent need to develop an efficient Clostridium butyricum delivery system to fully harness its potential in promoting mucosal barrier restoration and modulating immune responses. Advanced encapsulation strategies, including microencapsulation and nano-armored coating, have demonstrated significant efficacy for probiotic delivery [15]. However, the increased permeability of damaged intestinal epithelial cells can facilitate bacterial translocation, thereby exacerbating local inflammation and potentially triggering extraintestinal complications, which remains a key challenge [16]. Biocompatible polymer-based microspheres can be applied as coatings to injured mucosal surfaces, thereby accelerating the healing of the intestinal lining [17]. The most commonly used biopolymer building blocks for fabricating simple microgels (Mgel) include natural materials such as sodium alginate (SA), pectin, polysaccharides, and proteins [18]. Among these, polysaccharides represent the most bioactive constituents, exhibiting a wide range of biological activities, including metabolic regulation, immune modulation, and anti-inflammatory, antioxidant, and anticancer effects [19]. While an antioxidative sodium alginate hybrid hydrogel with NIR-controlled NO releasing for diabetic wound healing via reduced inflammation and enhanced angiogenesis, Polygonatum polysaccharide (PP), a traditional herbal component long used in Chinese medicine, has demonstrated broad anti-inflammatory and antioxidant effects in biomedical applications, along with a favorable long-term safety profile [20, 21]. Studies have shown that PP can modulate gut microbiota composition, promote SCFA production, and restore intestinal barrier integrity, highlighting its potential as an effective therapeutic agent for IBD [22, 23]. However, its oral application faces several challenges, including instability in gastric acid, rapid metabolic clearance, poor targeting and retention in inflamed regions, and low bioavailability. Therefore, the fabrication of PP-integrated hydrogel microspheres may offer an effective strategy to prevent premature degradation in vivo and enable localized colonic release, thus ensuring sustained therapeutic effects. In this study, we developed double-network microspheres by incorporating PP into Ca2+-cross-linked SA for the encapsulation of the obligate anaerobe Clostridium butyricum (JHP6). Conventional single-network SA-based microgels exhibit limitations such as low mechanical strength and poor structural integrity, often necessitating additional cross-linking. PP, owing to its antioxidant and anti-inflammatory properties, serves not only as a prebiotic for probiotics but also enhances the mechanical robustness of the microgels, enabling sustained release within the GIT. As shown in Scheme 1, in a dextran sulfate sodium (DSS)-induced acute colitis model, Mgel/JHP6 represents a promising strategy for modulating the IBD microenvironment by promoting probiotic colonization in the intestine. This, in turn, helps restore the intestinal microbiota balance, enhances SCFA production, and improves mitochondrial function to facilitate epithelial repair. In parallel, plant polysaccharides can form additional secondary cross-linking networks through intermolecular interactions. This composite cross-linked structure synergistically enhances the cross-linking density of the microsphere polymer matrix and improves its physicochemical stability [24]. Moreover, if the polysaccharide-based wall materials can concurrently serve as prebiotics for the gut microbiota, it would be even more advantageous. Preparation of Mgel/JHP6 and the underlying mechanism of immune regulation in colitis. Orally delivered Mgel/JHP6 is preferentially retained in the intestine, resulting in attenuation of intestinal inflammation, repair of the intestinal barrier, and restoration of mitochondrial function. These effects are achieved through increased SCFAs levels, synergistic action of PP, and remodeling of microbial metabolites. (Abbreviations: MCT1, monocarboxylate transporter 1; SMCT1, sodium-coupled monocarboxylate transporter 1) Materials and methods Materials Escherichia coli Nissle 1917 (EcN), engineered with a DsRed plasmid, was obtained from the laboratory of Professor Dongchang Sun, Zhejiang University of Technology [25] JHP6 was obtained from Zhejiang Academy of Agricultural Sciences. Luria–Bertani (LB) and reinforced clostridial medium (RCM) were used as the medium for cloning. Sodium alginate was purchased from Shanghai Aladdin Biochemical Technology Co., Ltd. (SA, medium viscosity; mannuronate/guluronate ratio = 1/1; Mw: 100,000–170,000 g/mol) PP was purchased from Shaanxi Ciyuan Biotech Co., Ltd. (Baoji, China). 2,2’-Azobis(2-amidinopropane) dihydrochloride (AAPH), dextran sulfate sodium (DSS), FITC, and DCFH-DA were purchased from Aladdin (Shanghai, China). CCK-8 was purchased from Beyotime Biotechnology (Shanghai, China). MTT was purchased from Sangon Biotech (Shanghai) Co., Ltd. Cytokine (TNF-α and IL-1β)-detecting ELISA kits were purchased from Hangzhou Lianke Biotech Co., Ltd. Cytokine (NAD + , ATP synthase, SDH, IDH, α-KGDH, and SIRT1)-detecting ELISA kits were purchased from Jingmei Biotechnology Co., Ltd. (Jiangsu, China). MDA, CAT, SOD and GSH-Px kits were purchased from Nanjing Jiancheng Bioengineering Research Institute Co., Ltd. ATP kits were purchased from Shanghai Beyotime Biotechnology Co., Ltd. JC-10 MMP Assay Kit was purchased from Yeasen Biotechnology (Shanghai) Co., Ltd. VAHTS Serum/Plasma Circulating DNA Kit and Equalbit dsDNA HS Assay Kit were purchased from Nanjing Vazyme Biotech Co., Ltd. Preparation of the probiotic suspension JHP6 was anaerobically cultured in sterile RCM, while EcN was cultured in sterile LB liquid medium at 200 rpm at 37 ℃ for 24 h. The cells were suspended in PBS to obtain a suspension with the desired concentration. Microgel fabrication process The SA (1.5% w/v), PP (1% w/v) and JHP6 suspension (5 × 108 CFU/mL) were dissolved in water and mixed thoroughly. Beads were quickly extruded from a 1 mL syringe and injected into a 100 mL beaker containing a 1% (w/v) CaCl2 solution through a needle (0.16 mm inner diameter), stirred gently, and collected by gravity settling. The resulting product was named Mgel. Scanning electron microscope (SEM) Following the described Mgel preparation protocol, Mgel/DsRed-EcN was fabricated, pre-frozen at -80 °C for 2 h, and then lyophilized in a freeze dryer for 24 h. The freeze-dried Mgel and Mgel/DsRed-EcN powder were mounted on a tape and fixed to the circular stub of an aluminum specimen. The samples were then coated with gold using ion sputter (JS-20031, KYKK) and imaged with SEM (Nova NanoSEM 450, FEI, America) at an accelerator voltage of 15 kV. Elemental mapping was performed using energy-dispersive X-ray spectroscopy (EDS). Fourier transform infrared (FT-IR) spectroscopy The dried microgels were ground into a powder, dissolved in KBr, and analyzed using a FTIR spectrometer (Nicolet iS50, Thermo Fisher, America). Spectra were recorded in the range of 550–4000 cm−1 with a resolution of 4 cm−1. Thermal analysis Thermal stability was measured using a synchronous thermal analyzer (STA 449 F3 Jupiter, NETZSCH, Germany) through TGA and DSC in a nitrogen atmosphere (50 mL·min−1). Approximately 10 mg of the sample was sealed in an aluminum disk and heated from 30 to 250 °C at a heating rate of 10 ℃⋅min−1. An empty platinum pan was used as a reference. External environment resistance assessment for Mgel/EcN The protective effects of Mgel on EcN against external environments were investigated. These external environments included SGF (pH 1.2, prepared by dissolving 100 mg of sodium chloride, 40 mg of pepsin, and 70 μL of hydrochloric acid in 100 mL of ddH₂O), SIF (pH 7.4, 100 mL PBS, 160 mg trypsin) and antibiotic solutions (kanamycin (20 μg/mL) and 1‰ ampicillin solution). RT-qPCR detection in vitro To examine the anti-inflammatory and anti-oxidant effects of PP, LPS-stimulated Raw264.7 and AAPH induced Caco-2 cells were firstly constructed. Briefly, RAW 264.7 cells and Caco-2 cells were seeded in 6-well plates (2 × 105 cells/well), incubated with LPS (1 μg/mL for 3 h) and AAPH (5 μM for 24 h) treatments. After incubation with different concentrations of PP, the gene expressions of inflammatory related cytokines (iNOS, IL-6, IL-1β, and TNF-α) and antioxidant-related genes (CAT, SOD2, GPx1, and GPx3) were detected. The gene primer sequences involved were shown in were detected according to the literature [26, 27]. The gene primer sequences involved were shown in Table S3 in the Supplementary Information. Animals SPF male C57BL/6 mice (6–8 weeks old) were purchased from the China National Laboratory Animal Center (Shanghai, China). Retention effect of Mgel in the mouse intestine Mice were randomly assigned to two groups: DsRed-EcN and Mgel/DsRed-EcN. The mice were given 200 μL of various formulations containing 1 × 109 CFUs of EcN by gavage. Mice were euthanized at 3, 6, 24, and 48 h post-administration, and their GIT were imaged using the IVIS small animal fluorescence in vivo imaging system (Em = 558 nm, Ex = 583 nm) (IVIS®Lumina, Biospace Lab, France). To quantified the residence of DsRed-ECN in vivo, the feces of mice were taken at 0, 1, 2, 3, and 7 d and fecal DNA was extracted with magnetic DNA Extraction Kit. The relative abundance of EcN was quantified by qPCR, which determined the EcN-related gene (uidA) DNA copy numbers with the forward primer (A T G G A A T T T C G C C G A T T T T G C) and reverse primer (A T T G T T T G C C T C C C T G C T G C). The fluorescence signal was recorded at the end point of each cycle during the 40 cycles (initial at 50 °C for 2 min and 95 °C for 5 min, followed by 40 cycles of at 95 °C for 15 s, 56 °C for 30 s, and 72 °C for 1 min). The genes were normalized to the 16S rRNA internal control. Prophylactic and therapeutic effect of Mgel/JHP6 against DSS-induced colitis Mice were divided into five groups: healthy, model (DSS), JHP6, PP and Mgel/JHP6. The mice were given 200 μL of various formulations containing 1 × 108 CFUs of JHP6 or 100 mg/kg PP by oral gavage every day throughout the experimental period. Except for the health group, 2.5% DSS was added to the drinking water for the first 7 days to induce acute colitis. On day 12, the mice were sacrificed and colon tissues were taken and photographed. Whole blood and serum of mice were collected. All dissected tissues were frozen at -80 °C. Colonic contents were collected and sent to Novogene Co., Ltd. (Beijing, China) for 16S rRNA microbial sequencing. Colon tissue DNA extraction and mtDNA content assay The magnetic DNA extraction kit was applied to extract colon tissue DNA samples according to the manufacturer’s instructions. The concentrations and purity of the obtained DNA samples were measured using an ultra-micro ultraviolet spectrophotometer (Bioteke Corporation, China). The Rpl13 gene was used as a targeting nDNA, and the mitochondrial DNA encoded gene ND1 was used as a targeting mtDNA. After normalized mtDNA to nDNA, the samples were diluted to 10 ng/μL with ddH2O for qPCR analysis, and the primers for specific genes were listed in Table S4. Relative abundance of bacterial assays Using a magnetic DNA extraction kit, fecal bacterial DNA samples were extracted according to the manufacturer’s instructions. Relative abundance of Akkermansiaceae, Desulfovibrionaceae, Butyricum, Verrucomicrobia and Bacteroidetes was determined by qPCR. The bacterial gene primer sequences are shown in Table S5. Histopathology studies In brief, the colon was fixed in a 4% paraformaldehyde solution, followed by paraffin embedding.H&E staining was performed to evaluate the morphology of colon tissue. AB/PAS staining was used to evaluate goblet cells. MUC2 immunohistochemical staining was used to assess mucin expression. ZO-1, claudin and occludin immunohistochemical staining were used to evaluate tight junction protein expression. The histological images were observed under a microscope. Determination of intestinal SCFAs 100 mg of feces was homogenized with 500 μL of ultrapure water for 2 min, followed by acidification with 20 μL of sulfuric acid and vortex mixing. Subsequently, 800 μL of diethyl ether was added, and the mixture was vortexed for 30 s and left to stand for 30 min. The sample was centrifuged, and the supernatant was used to remove residual moisture with anhydrous sodium sulfate. After centrifugation, the supernatant was collected and transferred into a vial for subsequent GC analysis (Nexis GC-2030, Shimadzu, Japan). Statistical analyses All data were representative results from at least three independent experiments (n ≥ 3) and were presented as means ± SEM. Statistical analyses included the two-sample t-test and one-way analysis of variance (ANOVA). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 were considered statistically significant differences. Results and discussion Antioxidant, anti-inflammatory activities and Cytotoxicity of PP PP is a fine brown powder extracted from the dried rhizome of Polygonatum, with a purity exceeding 95% (Fig. 1F). Five monosaccharides were identified by comparing the chromatographic profiles with a mixed standard of 16 sugars (Fig. 1A, B). The chemical antioxidant activity of PP was evaluated using the total antioxidant capacity (T-AOC) assay, the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay, and the hydroxyl radical (OH·) scavenging assay. As shown in Fig. 1C-E, PP exhibited excellent antioxidant activity in a concentration-dependent manner. Cytotoxicity tests revealed that PP exerted no cytotoxic effects on Caco-2 cells at concentrations up to 200 μg/mL (Fig. 1G). Therefore, three concentrations (50, 100, and 200 μg/mL) were selected for subsequent cell experiments. Evaluation of anti-inflammatory, antioxidant and cytotoxic properties of PP. Ion chromatogram of (A) mixed 16 sugars standard and (B) PP. (C) T-AOC, (D) DPPH free radical and (E) hydroxyl radical scavenging ability of PP. (F) Extraction of PP from the Polygonatum plant. (G) Cytotoxicity assessment of PP on Caco-2 cells. (H) IL-1β levels in RAW cells supernatant. Relative mRNA levels of (I) proinflammatory and (J) antioxidant enzymes related gene expression. n = 6. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 IBD is characterized by chronic inflammation and oxidative stress in the intestines. To investigate the potential anti-inflammatory effects of PP, RAW 264.7 cells were stimulated with lipopolysaccharide (LPS) in the presence or absence of PP. ELISA and real-time quantitative PCR (RT-qPCR) analyses in LPS-stimulated RAW 264.7 cells revealed that PP treatment at various concentrations significantly reduced the levels of MDA (Figure S1A) and IL-1β (Fig. 1H). In addition, the mRNA expression levels of inflammatory genes (IL-1β, NF-κB, iNOS, and MCP-1) were significantly downregulated (Fig. 1I), showing a significant reduction compared to the LPS group. AAPH was employed as a free radical generator to induce oxidative stress in Caco-2 cells, thereby simulating intestinal oxidative conditions. Under oxidative stress, PP markedly increased cell viability (Figure S1B) and upregulated the expression of antioxidant-related genes (CAT, SOD2, GPx1, and GPx3) (Fig. 1J), indicating strong cytoprotective effects. Collectively, these results suggest that PP is a promising multi-target microecological modulator with potent anti-inflammatory and antioxidant properties. Preparation and characterization of microgels SA, a natural polysaccharide biopolymer derived from brown seaweed, is known for its non-toxic, biocompatible, and cost-effective properties, making it an ideal material for encapsulation [28]. To confirm the delivery capability of the microgels, fluorescently DsRed-Escherichia coli Nissle 1917 (EcN) was used as a model strain. As shown in Fig. 2A, the rapid crosslinking between Ca2+ and SA solidifies the microparticles and effectively prevents bacterial leakage. The incorporation of PP contributed to the formation of smooth, brownish, and compact particles with diameters ranging from approximately 400 to 600 μm (Fig. 2F). Bright-field and fluorescence microscopy clearly revealed the spatial distribution of encapsulated bacteria through red fluorescence (Fig. 2D and E), indicating that the probiotics were successfully and uniformly embedded within the microgels. Meanwhile, the addition of PP to the culture medium did not inhibit the growth of EcN (Fig. 2G), suggesting that low concentrations of the plant-derived PP do not exert antibacterial effects. These results indicate that the probiotic-encapsulated microgels were successfully prepared without compromising bacterial growth. Preparation and characterization of Mgel. (A) Schematic illustration of Mgel/EcN preparation. (B) Digital photographs of Mgel/DsRed-EcN. (C) Morphology of Mgel/DsRed-EcN under the microscope. Morphology of (D) Mgel/DsRed-EcN and (E) FITC-Mgel/EcN under the fluorescence microscope. (F) Particle size distribution. (G) Growth curves of EcN with PP. (H) Morphology of Mgel and Mgel/DsRed-EcN under SEM. Micrographs of the Mgel/DsRed-EcN in (I) antibiotics, (J) SGF, and (K) SIF. n = 6 Scanning electron microscopy (SEM) images further confirmed that numerous probiotics were embedded within the microgels (Fig. 2H). Plate count analysis showed an encapsulation efficiency of 81.38 ± 1.53% for the microgels, significantly higher than that of SA single-network microgels (75.40 ± 0.67%). The highwater content of the microgels (92.81 ± 0.31%) facilitates prolonged probiotic viability. After 45 days of long-term storage, the microgels retained their structural integrity, and the probiotics encapsulated within remained highly viable (Figure S2). This suggests that the microgels are suitable for long-term probiotic preservation. Protecting probiotics during their passage through the GIT is essential for ensuring their reach to the colon. We investigated the encapsulation and release behavior of probiotics in microgels exposed to antibiotic solutions, simulated gastric fluid (SGF, pH 1.2), and simulated intestinal fluid (SIF). As shown in Fig. 2I and J, after incubation in the antibiotic solution and SGF for 2 h, Mgel/DsRed-EcN maintained its intact compact structure, with the internal bacterial fluorescence intensity remaining unaffected (Figure S3A). These observations confirm that bacterial viability remained fully uncompromised under harsh conditions. After 1 h of incubation in SIF, the microgels exhibited slight swelling, and between 6–12 h, they fragmented and released large quantities of probiotics (Fig. 2K). In contrast, the single-network SA-based microgel Mgel (SA)/DsRed-EcN exhibited premature disintegration in SIF (Figure S4), which may impair its ability to effectively deliver probiotics to the colon. Complete dissociation of Mgel was achieved within 10 min using a 3% (w/v) sodium citrate solution as a calcium ion chelating agent. CCK-8 cell viability assays further demonstrated that Mgel encapsulation markedly enhanced EcN survival under SGF and SIF conditions (Figure S3B), an effect attributed to the protective barrier function of the gel matrix against digestive enzymes and harsh pH environments. Meanwhile, an in vitro release experiment of probiotics from the Mgel showed that approximately 75% of DsRed-Ecn/Mgel probiotics were released in SIF within 6 h (Figure S3C and D), an effect attributed to the protective barrier function of the gel matrix against digestive enzymes and harsh pH environments.Together, these findings indicate that PP-containing microgels exhibit efficient probiotic encapsulation, could protect probiotics from damage of SGF and achieve efficient release in SIF, making them a promising platform for oral probiotic delivery through the GIT. We further investigated the effect of PP incorporation on microgel stability and elucidated the underlying mechanisms using energy-dispersive X-ray spectroscopy (EDS), Fourier-transform infrared spectroscopy (FTIR), atomic force microscopy (AFM), and thermogravimetric analysis (TGA). Elemental mapping of microgels without bacterial loading revealed a uniform distribution of carbon, oxygen, and calcium. The calcium content, a critical crosslinking element, was quantified as 2.7% in Mgel (SA) (Figure S5) and increased to 3.0% in Mgel (SA/PP) (Fig. 3A), attributed to additional calcium coordination sites provided by active functional groups in PP. This structural feature enhanced the crosslinking density of Mgel (SA/PP) by approximately 11.1% compared to Mgel (SA). Characterization of Mgel. (A) Elemental mapping of Mgel(SA/PP). (B) FTIR spectra, (C) Nanoindentation force-distance curves, (D) Young’s modulus, (E) TGA, and (F) DSC of Mgel(SA) and Mgel (SA/PP). n = 6, ***P < 0.001 As shown in Fig. 3B, the introduction of PP altered the infrared spectra of the microgels, notably enhancing hydrogen bonding in the O–H/N–H regions, increasing absorption by C-H groups, and modifying C = O and COO− vibrational patterns. In addition, changes in the fingerprint region indicated that the complex structure of PP significantly influenced the molecular Vibrational mode reconfiguration analysis confirmed that PP enhanced the compactness of the microgel network through multimodal interactions, including hydrogen bonding, ionic crosslinking, and topological entanglement. Vibrational mode reconfiguration analysis confirmed that PP enhanced microgel network compactness through multimodal interactions, including hydrogen bonding, ionic crosslinking, and topological entanglement. These findings provide a molecular-level rationale for the high encapsulation efficiency (81.4%) achieved by the Mgel (SA/PP) system. To assess the mechanical strength of the microgels, force-indentation distance profiles were obtained using AFM (Fig. 3C). A steeper slope in the curve indicated a higher elastic modulus, [29] confirming that the addition of PP enhanced microgel stiffness. The Young’s modulus of Mgel (SA/PP) was 528.25 ± 6.69 MPa, significantly higher than that of Mgel (SA) (484.68 ± 6.59 MPa), thereby verifying the mechanical reinforcement conferred by PP incorporation (Fig. 3D). This notable enhancement in mechanical strength was attributed to a robust three-dimensional network structure formed via interactions among PP chains, SA, and Ca2+ ions, which suppressed plastic deformation through reinforced intermolecular binding. Enhanced mechanical properties are favorable for maintaining the integrity of microgels during oral delivery and protecting probiotics in the harsh GIT. Finally, TGA coupled with differential scanning calorimetry (DSC) was employed to investigate the thermal decomposition behavior of the encapsulation systems. As shown in Fig. 3E and F, Mgel (SA/PP) exhibited improved thermal stability compared to the SA-only microgels, supporting its superior ability to maintain structural integrity under elevated temperatures. Enhanced intestinal retention and colonization of probiotics by microgels We further evaluated the colon-retentive properties of Mgel/DsRed-EcN in vivo. The distribution of DsRed-EcN and Mgel/DsRed-EcN throughout the GIT was monitored in real time in mice using an in vivo imaging system (IVIS). As shown in Fig. 4A, free DsRed-EcN rapidly entered the large intestine and diffused throughout the GIT by 3 h post-administration. By 6 h, most Mgel/DsRed-EcN remained localized within the GIT, whereas the fluorescence signal from free DsRed-EcN declined more rapidly, indicating a faster clearance rate. At 24 h, the intestinal fluorescence signal from Mgel/DsRed-EcN was markedly stronger than that of free DsRed-EcN, suggesting enhanced microbial colonization. Notably, even at 48 h, Mgel/DsRed-EcN still exhibited strong fluorescent signals in the large intestine, while signals from free DsRed-EcN were nearly undetectable across the entire GIT (Fig. 4A, B). High-efficiency colonization of Mgel/DsRed-EcN in the mouse intestine. (A) Fluorescence images and (B) intensity signals of the GIT of mice harvested with DsRed-EcN and Mgel/DsRed-EcN at 3, 6, 24, and 48 h after gavage. (C) Relative abundance of EcN in feces of groups DsRed-EcN and Mgel/DsRed-EcN on 0, 1, 2, 3, and 7 d. (D) Fluorescence signal intensity of DsRed-EcN in intestinal frozen sections of mice in groups DsRed-EcN and Mgel/DsRed-EcN on 1, 2, and 7 d after gavage. n = 3 in B and n = 6 in C. *P < 0.05, **P < 0.01, ***P < 0.001 EcN was selected as the model strain due to its well-annotated whole-genome sequence, which facilitates quantitative assessment of colonization through fecal RT-qPCR following oral administration. Mice receiving Mgel/DsRed-EcN showed significantly higher EcN DNA copy numbers on days 2, 3, and 7 post-gavage compared to those receiving free bacteria (Fig. 4C). To further investigate the spatial retention of probiotics, intestinal cryosections were examined. Strikingly, strong fluorescence signals from the Mgel/DsRed-EcN group were still visible on day 7 (Fig. 4D), indicating long-term retention and potential in situ proliferation of DsRed-EcN in the intestinal environment. This extended retention may in turn facilitate the fermentation of prebiotic components and potentiate therapeutic efficacy [30]. Role of butyrate in energy metabolism Preclinical and clinical studies have demonstrated that butyrate confers beneficial effects in promoting recovery in colitis animal models and patients with IBD. To further explore the impact of butyrate-producing probiotics on IBD, we investigated the role of butyrate in cellular energy metabolism in vitro. Butyrate demonstrated good biocompatibility across a range of concentrations (0.25–5 mM) in Caco-2 cells (Figure S6A). Based on this finding and prior literature, we selected three commonly used concentrations (0.25, 0.5, and 1 mM) for subsequent experiments. Under H2O2-induced oxidative stress, butyrate significantly increased cell survival (Figure S6B), ATP content (Figure S6C), and the expression of antioxidant-related genes (Figure S6F) in Caco-2 cells. As shown in Figure S6D and E, DCF fluorescence intensity in the butyrate-treated group was significantly lower than that in the PBS group under H2O2 treatment, indicating the ROS-scavenging capacity of butyrate. Similarly, butyrate treatment enhanced mitochondrial fusion and autophagy (Figure S7C). In the inflammatory RAW 264.7 cell model, butyrate treatment significantly reduced the levels of TNF-α (Figure S6G), pro-inflammatory gene expression (Figure S6H), and MDA (Figure S6I), while increasing the expression of β-defensin genes (Figure S6J). Disruption of mitochondrial membrane potential (MMP) is a hallmark of early-stage programmed cell death, reflecting impaired mitochondrial function [31]. In healthy cells, JC-10 accumulates in the mitochondrial matrix as red fluorescent aggregates, while in apoptotic and necrotic cells, it exists as monomers, resulting in green fluorescence. This red-to-green fluorescence shift enables the detection of MMP reduction. Butyrate treatment decreased mitochondrial depolarization in Caco-2 cells exposed to AAPH (Figure S7A, B), protecting against oxidative stress-induced apoptosis. In IBD, the loss of butyrate-producing bacteria leads to MMP depletion and barrier dysfunction in the epithelium, potentially triggering disease onset and exacerbating inflammation [32]. Overall, butyrate not only serves as an energy source for colonic cells but also exerts anti-inflammatory, antioxidant, antimicrobial, and mitochondrial-protective effects in intestinal epithelial cells (Figure S7D). We further validated its regulatory effects on G-protein-coupled receptors (GPR41, GPR43, and GPR109A) and histone deacetylases (HDAC1-4) in Caco-2 cells (Figure S8A) and RAW 264.7 cells (Figure S8B). The diverse biological functions of butyrate are attributed to the tissue-specific expression of GPRs and HDACs, along with their distinct affinities for SCFAs. Synergistic action on alleviation of DSS-induced colitis by Mgel/JHP6 Here, we utilized Clostridium butyricum JHP6, an intestinal microorganism isolated from pig feces, which was capable of producing butyrate at a concentration of 1.032 mM in culture medium (Figure S9). TEM and dynamic light scattering (DLS) analysis showed that JHP6 had an average cell size of approximately 3 μm (Figure S10). We evaluated the viability of JHP6 under various stress conditions, including heat exposure, antibiotic treatment, and post-lyophilization storage, with results summarized in Figure S11. More importantly, the effects of JHP6 were assessed in both healthy and colitis-induced mice. Continuous oral administration of JHP6 (108 CFU) for 12 days in healthy mice resulted in no detectable toxicity to major organs, hematological parameters, or hepatorenal function, indicating a favorable biosafety profile (Figure S12). As a monotherapy, JHP6 exhibited moderate efficacy in alleviating experimental colitis, as evidenced by partial restoration of body weight, improvement in disease activity index (DAI), increased colon length, reduced intestinal permeability (as indicated by decreased FITC-dextran leakage), alleviated colonic histopathological damage, and elevated MUC2 protein expression (Figure S13). These findings are consistent with our previous results [12]. Epidemiological studies have shown that early-life antibiotic exposure disrupts the gut microbiota and is associated with an increased risk of developing IBD. [33] In our study, JHP6 also demonstrated therapeutic effects in antibiotic-pretreated colitis mice (Figure S13), suggesting that its beneficial action may occur independently of host microbiota modulation and primarily rely on the direct effects of butyrate. This provides a promising strategy for treating antibiotic-associated IBD. Finally, hematological analysis, serum biochemical profiling, and histopathological examination (H&E staining) of major organs from colitis mice treated with or without JHP6 revealed no significant adverse effects, further supporting the safety of JHP6 in the colitis model (Figure S14). Accumulating evidence suggests that probiotics and their derivatives exhibit superior antioxidant capacity in facilitating tissue repair beyond the gut, as evidenced by their protective effects against oxidative stress in skin damage [34]. We hypothesized that the harsh GIT leads to the death of most ingested probiotics, thereby resulting in low colonization efficiency and limited therapeutic efficacy in the colon. CCK-8 assays revealed a significant reduction in JHP6 viability under SGF and SIF, with a survival rate of only 30.9% after 2 h of SGF exposure (Figure S15). To enhance therapeutic outcomes, we leveraged the protective properties of microgels to improve the delivery and efficacy of JHP6 in colitis treatment. Mgel/JHP6 was prepared using the same method as previously described, and successful encapsulation of DiR-labeled JHP6 was confirmed using the lipophilic fluorescent dye DiR (Figure S16). The experimental scheme for establishing acute colitis using DSS is illustrated Fig. 5A. Two treatment groups were designed, one receiving PP (100 mg/kg) and the other JHP6 (108 CFU), to systematically evaluate the synergistic effects of microencapsulation technology combined with the prebiotic PP on the therapeutic potential of the JHP6 strain. The PP dose was selected based on the clinically recommended dose of Polygonatum sibiricum in the Chinese Pharmacopoeia and converted across species using body surface area normalization [35]; an equivalent PP amount was incorporated into Mgel/JHP6. Preventative efficacy of Mgel/JHP6 in DSS-induced colitis. (A) Schematic diagram of colitis model mice and administration methods. (B) Body weight and (C) DAI scores from 0 to 11 days. (D) Colonic histological scores calculated from H&E sections. (E) Digital photographs of colons. (F) Quantification of colon length. (G) H&E of distal colon tissue from different groups harvested on day 12. n = 6 in B, C and F. n = 3 in D. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 During treatment, body weight and the DAI were monitored, both of which are reliable indicators of intestinal inflammation. DSS-treated mice exhibited less weight gain and higher DAI scores compared to healthy controls. In contrast, mice treated with Mgel/JHP6 showed significant improvements in both parameters (Fig. 5B and C). On day 12, all mice were sacrificed for colon length measurement and histopathological assessments to evaluate the severity of colonic inflammation blindly. Mice treated with Mgel/JHP6 exhibited a significantly longer colon length compared to the DSS model group, indicating a powerful therapeutic effect (Fig. 5E and F). Histological analysis of experimental colitis revealed severe mucosal damage, characterized by atrophic, branched, and irregular crypts; extensive infiltration of inflammatory cells into the submucosa; reduced goblet cell numbers; and larger gaps between the mucosa and sub-mucosa (Fig. 5G). Notably, Mgel/JHP6 treatment markedly alleviated these morphological abnormalities and restored the colonic architecture to a near-normal appearance in colitis mice (Fig. 5D and G). Tight junction proteins, which serve as essential connectors between epithelial cells in the intestinal mucosa, play a critical role in maintaining intestinal homeostasis. To evaluate the integrity of the epithelial barrier, we examined the colonic expression of three key tight junction proteins: Claudin, Occludin, and ZO-1. In the experimental colitis model, immunofluorescence imaging revealed disrupted and diminished expression of these proteins, which was markedly restored following Mgel/JHP6 treatment (Fig. 6A-C, E–G). Goblet cells in the colon are responsible for producing mucus, primarily composed of the mucin protein MUC2. [36] Representative images of AB/PAS staining, along with immunohistochemical staining for MUC2, are shown in Fig. 6D and I. Compared with the control group, DSS-treated mice exhibited crypt loss, mucosal erosion, and reduced MUC2 protein expression. Mgel/JHP6 treatment significantly reversed these pathological changes and enhanced MUC2 secretion (Fig. 6H). Mgel/JHP6 restored tight junction proteins and mucins. (A-D) Representative immune-fluorescence images of the colon epithelium Claudin red, Occludin red, ZO-1 red and DAPI blue and immunohistochemical staining of MUC2. (E–H) Corresponding quantitative analysis of Claudin, Occludin, ZO-1 and MUC2-stained coverage. (I) AB/PAS of colon tissue. n = 4. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 Collectively, these findings indicate that Mgel/JHP6 not only restores the physical barrier by reinforcing tight junction integrity,but also enhances the chemical barrier through increased mucus production. This dual-action mechanism contributes synergistically to the maintenance of intestinal homeostasis. Repair of the intestinal epithelium requires the continuous proliferation and differentiation of stem cells located at the crypt base. LGR5, a canonical target of the Wnt/β-catenin signaling pathway, serves as a key marker for intestinal stem cell proliferation and their differentiation into diverse cell types. Rspo3 has been shown to enhance LGR5 expression, thereby promoting the regeneration of damaged intestinal tissue [37]. In our study, the mRNA levels of two representative stem cell proliferation markers (LGR5 and Rspo) in DSS- damaged colon tissue were restored to near-normal levels following Mgel/JHP6 administration (Figure S17), suggesting its excellent capacity to promote epithelial repair. Excessive ROS and a pro-inflammatory microenvironment can compromise intestinal barrier integrity. To evaluate the antioxidant potential of Mgel/JHP6, we assessed ROS-related indicates in serum. As shown in Fig. 7A-D, Mgel/JHP6 treatment significantly reduced MDA levels while enhancing the activities of key antioxidant enzymes, including SOD, CAT, and GSH-Px, indicating effective alleviation of oxidative stress in colitis mice. Mgel/JHP6 restored oxidative stress, inflammation, SCFAs and mitochondrial function. (A-G) The contents of SOD, CAT, GSH-Px, MDA, cfDNA, TNF-α, and IL-1β in serum. (H) Relative mRNA levels of TNF-α in the colon. (I) Concentrations of SCFAs (acetate, propionate, butyrate, and valerate) in the colon contents. (J-M) ATPase, relative mtDNA, ATP and NAD + contents in the colon. (N) Schematic representation of the underlying mechanism of Mgel/JHP6 in vivo. n = 4. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 Cell-free DNA (cfDNA), also known as circulating free DNA, can trigger multiple inflammatory signaling pathways and exhibit strong immune-stimulatory effects [38]. Elevated plasma cfDNA levels have been positively associated with IBD severity [39]. In our study, serum cfDNA concentrations increased from 76 ng/mL in healthy controls to 173 ng/mL in colitis mice, and returned to the baseline following Mgel/JHP6 treatment (Fig. 7E). Targeted clearance of cfDNA to alleviate its mediated inflammation offers a promising new therapeutic strategy for IBD [39]. Moreover, cfDNA has emerged as a valuable biomarker for predicting, monitoring, and guiding IBD treatment [40]. We also examined the levels of key pro-inflammatory cytokines. Mgel/JHP6 significantly reduced serum concentrations of TNF-α and IL-1β (Fig. 7F and G), as well as the mRNA expression of TNF-α, IL-1β, and NF-κB in colonic tissues (Fig. 7H and S18), demonstrating its potent anti-inflammatory efficacy. Mgel/JHP6 modulates the abundance and diversity of gut microbiota by increasing the relative abundance of SCFA-producing bacteria. Additionally, the administration of PP further augmented SCFA production [41]. Given that dysregulated SCFA levels are a known susceptibility factor for IBD, [10] we quantified SCFA metabolites in colonic contents using gas chromatography-mass spectrometry (GC–MS). Mgel/JHP6 significantly elevated levels of acetate, propionate, butyrate, and valerate compared with DSS controls (Fig. 7I). SCFAs serve as the primary energy source for colonic epithelial cells, guide the development of regulatory immune cells, and exert anti-inflammatory effects through GPRs signaling and HDACs inhibition. Notably, SCFAs also possess chemopreventive potential by suppressing colitis-associated tumorigenesis [42]. The elevated butyrate content, in synergy with PP, further enhanced antioxidant and anti-inflammatory effects via precise modulation of the intestinal microenvironment. Moreover, traditional Chinese medicines such as Panax ginseng, Astragali Radix and Scutellaria Radix have shown therapeutic potential in alleviating IBD through interactions with the gut microbiota [43]. In our study, the combined delivery of PP and JHP6 restored SCFA abundance and altered the gut microbial community structure, suggesting the potential of plant polysaccharides to modulate intestinal symbiosis. These microbial metabolites contribute to reshaping the immune microenvironment and promoting more effective anti-inflammatory responses. IBD is increasingly recognized as a metabolic disorder associated with mitochondrial dysfunction, characterized by impaired energy production in intestinal epithelial cells and damage to all five oxidative phosphorylation (OXPHOS) complexes. [44] As a critical energy source and a signaling molecule, butyrate can regulate epithelial barrier function and immune response. In addition, accumulating evidence suggests that butyrate modulates mitochondrial dynamics and autophagy, thereby contributing to the maintenance of cellular homeostasis. Mitochondria act as a critical driver for the regeneration and differentiation of intestinal stem cells to maintain the mucosal barrier [45]. Based on these insights, we hypothesized that Mgel/JHP6 resulted in increased butyrate levels in the colon, which could regulate mitochondrial energy metabolism, thereby facilitating the restoration of mitochondrial function and mucosal renewal. The re-established mitochondrial function, in turn, would enhance butyrate uptake and utilization via OXPHOS to produce ATP, establishing a positive feedback loop that sustains epithelial energy demands. To test this, we assessed the activities of key enzymes involved in the tricarboxylic acid (TCA) cycle and OXPHOS. As shown in Fig. 7J and S19, the Mgel/JHP6 group significantly restored the reduced enzymatic activities of ATP synthase, isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), and α-ketoglutarate dehydrogenase (α-KGDH) observed in DSS-induced colitis. Furthermore, both the activities and gene expression levels of mitochondrial biogenesis-related enzymes, including silent information regulator 1 (SIRT1), PPAR-γ coactivator-1α (PGC-1α), and mitochondrial transcription factor A (TFAM) showed the same tendency (Figure S20 and Figure S21). In parallel, levels of mitochondrial DNA (mtDNA), ATP, and NAD + were markedly decreased in DSS mice but were restored to near-normal levels in the Mgel/JHP6 group (Fig. 7K-M). These results demonstrate that probiotic-based microgels effectively reverse mitochondrial dysfunction and reprogram energy metabolism through synergistic actions of butyrate and PP, potentially facilitating mucosal repair in colitis. Butyrate oxidation deficiency is a hallmark of colonic energy depletion. Failure to catabolize butyrate leads to impaired fatty acid metabolism and cellular energy crisis, which further exacerbates intestinal inflammation, most likely through mitochondrial dysfunction [46]. Restoration of mitochondrial function is therefore expected to reinstate butyrate oxidation capacity. We next assessed the expression levels of butyrate transporters, including monocarboxylate transporter 1 (MCT1) and sodium-coupled monocarboxylate transporter 1 (SMCT1), as well as critical enzymes involved in butyrate β-oxidation, such as short-chain acyl-CoA dehydrogenase (ACADS), hydroxyacyl-CoA dehydrogenase (HADH), and carnitine palmitoyltransferase 1A (CPT1A). Compared to healthy controls, DSS-induced colitis significantly downregulated the expression of these genes, whereas Mgel/JHP6 treatment effectively restored their expression levels (Figure S22). Collectively, these findings suggest that the abundant butyrate produced by Mgel/JHP6 serves not only as a direct energy substrate but also as a mitochondrial signaling molecule. It supports efficient OXPHOS and energy production in healthy mitochondria, thereby ameliorating colonic inflammation through metabolic reprogramming (Fig. 7N). Gut microbiota modulation by Mgel/JHP6 Dysbiosis is closely associated with various diseases, including obesity, cancer, and IBD [47]. To investigate microbial alterations, we performed 16S rRNA amplicon sequencing of fecal samples. The species accumulation box plot confirmed the adequacy of the sample size for further analysis of microbial richness (Figure S23). Venn and petal diagrams revealed limited overlap between the DSS group and the JHP6 or Mgel/JHP6 groups, suggesting substantial differences in gut microbial composition (Figure S24). Alpha diversity metrics, including Shannon and Simpson indices, showed significantly increased species richness and evenness in the Mgel/JHP6-treated group compared to the DSS group (Fig. 8A, B). Furthermore, principal component analysis (PCA) and non-metric multidimensional scaling (NMDS) of β-diversity revealed that the gut microbiota of colitis mice treated with Mgel/JHP6 was closer to that of healthy mice than to other treatment groups (Fig. 8C, D), indicating that Mgel/JHP6 modulates gut microbiota toward a healthier profile. Regulation of gut microbial homeostasis. α-diversity was determined by Shannon index (A) and Simpson index (B). β-diversity was determined by PCA (C) and NMDS (D). (E) Relative abundance of the top 30 family in gut microbiota (%). (F) Species evolutionary tree at genus level. Relative abundance (%) of Akkermansiaceae (G) and Desulfovibrionaceae (H). Relative abundance of Butyricum (I), Verrucomicrobia (J) and Bacteroidetes (K). n = 4 in A-H, n = 6 in I-K. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 At the phylum level (Fig. 8E), Mgel/JHP6 treatment notably increased the relative abundance of the beneficial bacterium Akkermansia muciniphila (Akk) (Fig. 8G) while reducing the abundance of the harmful Desulfovibrionaceae (Fig. 8H). Akk is a beneficial microorganism residing in the mucus layer of the intestine and is associated with gut barrier protection, immune modulation, and microbiota regulation [48]. It has been reported to slow the onset and progression of diabetes, obesity, and IBD in mice [49]. Conversely, Desulfovibrio species produce hydrogen sulfide (H2S), which can disrupt the intestinal barrier and exacerbate inflammatory responses [50]. Fecal RT-qPCR further confirmed that all treatment groups, particularly Mgel/JHP6, significantly enhanced the abundance of Butyricum, Verrucomicrobia, and Bacteroidetes in the gut microbiota of mice (Fig. 8I-K). Notably, Akk is the most representative species within the Verrucomicrobia phylum. Both Butyricum and Bacteroidetes contribute to maintaining epithelial barrier function and immune homeostasis through SCFAs production [51]. To explore phylogenetic relationships at the genus level, representative sequences of the top 50 genera were aligned to construct a genus-level species evolutionary tree (Fig. 8F). The healthy and treatment groups displayed higher microbial diversity and compositional balance compared to the DSS group. Of note, Proteobacteria, a phylum commonly associated with gut inflammation and immune dysregulation, was markedly enriched in the DSS group, [52] while γ-Proteobacteria abundance was significantly reduced following Mgel/JHP6 treatment (Figure S25). γ-Proteobacteria have been implicated in the exacerbation of IBD via multiple pro-inflammatory mechanisms [53, 54]. Collectively, these findings suggest that dysbiosis in IBD is characterized by enrichment of pathogenic bacteria and depletion of beneficial commensals. The healthy intestinal microbiome plays a crucial role in nutrient metabolism, immune regulation, maintaining gut barrier integrity, and supporting host homeostasis [55]. Mgel/JHP6 treatment reshapes the gut microbiota by reducing harmful taxa and enriching SCFA-producing bacteria, which may help restore immune balance and intestinal homeostasis. Conclusions In conclusion, we successfully developed double-network microspheres by integrating PP with calcium-crosslinked SA for the targeted delivery of Clostridium butyricum JHP6 in IBD therapy. PP functioned as a multifunctional microenvironmental regulator, exhibiting potent broad-spectrum antioxidant and anti-inflammatory activities in vitro. In addition, PP enhanced the mechanical strength and thermal stability of the microgels through a polysaccharide–metal coordination framework, while simultaneously acting as a prebiotic to support beneficial gut microbiota metabolism. The resulting microspheres enabled precise colonic delivery of both PP and JHP6, enhancing probiotic viability and therapeutic efficacy by mitigating the pro-inflammatory response. Notably, the elevated SCFA levels induced by this system promoted intestinal repair by restoring epithelial barrier integrity through the regulation of mitochondrial function. Taken together, this synergistic delivery platform offers a promising strategy for probiotic-based IBD intervention via mucosal healing and immune microenvironment modulation. Associated content The scoring system DAI; Histological scoring system of colon; Primer pairs for RT-qPCR; Ion chromatogram of mixed 16 sugars standard and PP; Evaluation of protectiveness of PP; Optical micrographs of the Mgel/DsRed-EcN in PBS at 4℃ for different days; Relative fluorescence intensity of microgel and growth curve of EcN and Mgel/EcN under different treatments; Optical micrographs of the Mgel(SA)/DsRed-EcN in SIF at different times; Elemental mapping of Mgel(SA); Evaluation of antioxidant and anti-inflammatory properties of butyrate; Butyrate exerts a protective effect on mitochondria under oxidative stress; Relative mRNA expression of GPRs and HDACs in Caco-2 cells and RAW 264.7 cells; The gas chromatography chromatogram of the supernatant from the JHP6 culture medium; Morphology and particle size distribution curve of JHP6; Growth curves of JHP6 under heat stress, antibiotic, and storage for 7 days under different temperatures after lyophilization; The safety of JHP6 in healthy mice; Monotherapy efficacy of JHP6 in DSS-induced colitis; The safety of JHP6 in DSS-induced colitis; Relative viability of JHP6 under SGF and SIF; Morphology of Mgel/JHP6 and Mgel/DiR-JHP6, and Mgel/DiR-JHP6 under the fluorescence microscope; Relative mRNA expression of intestinal stem cell proliferation and proinflammatory related gene; IDH, SDH, α-KGDH and SRIT1 content in the colon; Relative mRNA expression of PGC-1α, NRF-1 and TFAM; Relative mRNA expression of butyrate transporters and key enzymes involved in butyrate β-oxidation; Analysis of the microbial community by species accumulation boxplot; Venn/petal diagram of identified bacterial strains; Relative abundance of γ-Proteobacteria. Supplementary Information Additional file 1. Acknowledgements Not applicable. Author contributions H.Q.L., C.Y., J.Y.X.designed and funded this project. H.Q. L.and X.X.C. engineered of the material system. X.X.C. was responsible for cell experiments. X.X.C., F.J., and W.C.Z were responsible for animal experiments. H.Q.L, and X.X.C. were responsible for writing and revising this article. H.Q.L., and F.J. proofread the manuscript. X.X.C was responsible for data analysis. The corresponding authors provided funding support.All authors have reviewed the article.All authors have given approval to the final version of the manuscript. Funding This work was supported by the National Natural Science Foundation of China (42277279), Zhejiang Provincial Natural Science Foundation of China (No. LQN25C010005 and LY21E030011) and Key Scientific Research Projects of Xianghu Laboratory (2023C4S02002). Data availability No datasets were generated or analysed during the current study. Declarations Ethics approval and consent to participate All experimental procedures complied with the Zhejiang University of Technology’s Guide for the Care and Use of Laboratory Animals and the National Institutes of Health Guide for Care and Use of Laboratory Animals (Publication No. 85–23, revised 1996), and were approved by the Institutional Animal Care and Use Committee (IACUC) of Zhejiang University of Technology (Approval No. MGS20240320011). Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Jintao Cheng, Email: jintaocheng@zju.edu.cn. Yue Chen, Email: earnchen@163.com. Yuanxiang Jin, Email: jinyx@zjut.edu.cn. References Associated Data Supplementary Materials Additional file 1. Data Availability Statement No datasets were generated or analysed during the current study.